首页> 外文期刊>Journal of Medicine, Physiology and Biophysics >To compare the effect of cyclizine, prochlorperazine and ondansetron in inhibiting postoperative nausea and vomiting following laparoscopic cholecystectomy
【24h】

To compare the effect of cyclizine, prochlorperazine and ondansetron in inhibiting postoperative nausea and vomiting following laparoscopic cholecystectomy

机译:比较环丙嗪,氯丙嗪和恩丹西酮在腹腔镜胆囊切除术后抑制恶心和呕吐的作用

获取原文
获取外文期刊封面目录资料

摘要

Objective: To determine the efficacy of prochlorperazine, cyclizine and ondansetron in patients following laparoscopic cholecystectomy, in terms of prevention of vomiting and nausea. Study Type: Randomized Control Trial. Duration and Location of Study: Anaesthesia department of the Bahawal Victoria Hospital, Bahawalpur over a period of January, 2018 to January, 2019. Methodology: Total of 324 patients divided into Group P, group O and group C received prochlorperazine (10mg), ondansetron (4mg) and cyclizine (50mg) respectively. Every patient was asked to tell when he/she is feeling nauseous, vomited and used additional antiemetic drugs. Descriptive data was compared by applying ANOVA test and Chi-square or Fischer’s exact test was applied on nominal data. Computer software SPSS version 23 was used to statistically analyze the data. P ≤0.05 was taken as significant., Results: Although occurrence of side effects was slightly higher in group-P, but all the groups were not statistically diffrent (p-value 0.581, 0.500 and 0.544 for headache, dizziness and sedation, respectively). Nausea and vomiting was observed in 4.6% in group-O patients, 5.5% in group-C patients and 8.3% in group-P patients, difference being statistically insignificant (p=0.500). , Conclusion: From the results of this study it can be concluded that all the three drugs i.e. cyclizine, ondansetron and prochlorperazine are equally effective and there is no statistically significant difference in terms of prevention of vomiting and nausea in patients undergoing cholecystectomy through laparoscope.
机译:目的:从预防呕吐和恶心的角度,确定前氯哌嗪,环丙嗪和恩丹西酮在腹腔镜胆囊切除术后的疗效。研究类型:随机对照试验。研究的持续时间和地点:2018年1月至2019年1月,位于Bahawalpur的Bahawal Victoria医院麻醉科。方法:总共324名患者分为P组,O组和C组,分别接受氯丙嗪(10mg),恩丹西酮(4毫克)和Cyclizine(50毫克)。要求每个患者告诉他/她何时感到恶心,呕吐并使用了其他止吐药。通过应用方差分析比较描述性数据,对名义数据进行卡方检验或菲舍尔精确检验。使用计算机软件SPSS 23版对数据进行统计分析。 P≤0.05为显着。,结果:尽管P组的不良反应发生率略高,但所有组的统计学差异均不明显(头痛,头晕和镇静的p值分别为0.581、0.500和0.544)。 。 O组患者中有4.6%的恶心和呕吐,C组患者中有5.5%,P组患者中有8.3%,差异无统计学意义(p = 0.500)。结论:从这项研究的结果可以得出结论,通过腹腔镜进行胆囊切除术的患者的三种药物,即cyclizine,恩丹西酮和氯丙嗪同等有效,在预防呕吐和恶心方面没有统计学上的显着差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号